Mark Ray and Sarah Ernst are noted for advising Arbor Pharmaceuticals in its acquisition of XenoPort for a total equity value of approximately $467 million.
In the News
May 27, 2016
Law360 | Don’t Miss It: Hot Deals & Firms We’re Following This Week
Media Contact